BIOMARIN PHARMACEUTICAL INC Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for April 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 10,000 | 264,900 | 58,513 | |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 10,000 | 264,900 | 68,513 | |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 10,000 | 264,900 | 58,513 | |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 79.34 | 10,000 | 793,400 | 302,498 | 312.5 K to 302.5 K (-3.20 %) |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 10,000 | 264,900 | 68,513 | |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 10,000 | 264,900 | 312,498 | 302.5 K to 312.5 K (+3.31 %) |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 79.34 | 10,000 | 793,400 | 302,498 | 312.5 K to 302.5 K (-3.20 %) |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.91 | 10,000 | 789,100 | 302,498 | 312.5 K to 302.5 K (-3.20 %) |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 10,000 | 264,900 | 312,498 | 302.5 K to 312.5 K (+3.31 %) |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 10,000 | 264,900 | 312,498 | 302.5 K to 312.5 K (+3.31 %) |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 78.91 | 10,000 | 789,100 | 302,498 | 312.5 K to 302.5 K (-3.20 %) |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 10,000 | 264,900 | 312,498 | 302.5 K to 312.5 K (+3.31 %) |
Apr 20 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | M | 26.49 | 2,709 | 71,761 | 0 | |
Apr 20 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 79.58 | 2,709 | 215,582 | 68,440 | 71.1 K to 68.4 K (-3.81 %) |
Apr 20 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Buy | M | 26.49 | 2,709 | 71,761 | 71,149 | 68.4 K to 71.1 K (+3.96 %) |
Apr 20 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | M | 26.49 | 2,709 | 71,761 | 0 | |
Apr 20 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 79.58 | 2,709 | 215,582 | 68,440 | 71.1 K to 68.4 K (-3.81 %) |
Apr 20 2021 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Buy | M | 26.49 | 2,709 | 71,761 | 71,149 | 68.4 K to 71.1 K (+3.96 %) |
Apr 19 2021 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 26.49 | 7,500 | 198,675 | 0 | |
Apr 19 2021 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 76.90 | 7,500 | 576,750 | 18,850 | 26.4 K to 18.9 K (-28.46 %) |
Apr 19 2021 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 26.49 | 7,500 | 198,675 | 26,350 | 18.9 K to 26.4 K (+39.79 %) |
Apr 09 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 78.81 | 1,537 | 121,131 | 58,250 | 59.8 K to 58.3 K (-2.57 %) |
Apr 02 2021 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | EVP, Chief Financia ... | Sell | S | 76.30 | 5,692 | 434,300 | 31,016 | 36.7 K to 31 K (-15.51 %) |
Apr 01 2021 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 74.79 | 1,652 | 123,553 | 59,787 | 61.4 K to 59.8 K (-2.69 %) |